Anti-breast cancer activity of curcumin on the human oxidation-resistant cells ZR-75-1 with γ-glutamyltranspeptidase inhibition

Journal of Experimental Therapeutics and Oncology

Volumn 8, Issue 3, 2010, Pages 261-266

  Quiroga, Analía ^a   Quiroga, Patricia L ^a   Martínez, Estefanía ^a   Soria, Elio A ^a,b   Valentich, Mirta A ^a,b  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

glutamyltranspeptidase; Apoptosis; Biomarker; Breast cancer; Copper; Curcumin; Oxidative stress

Indexed keywords

COPPER SULFATE; CURCUMIN; GAMMA GLUTAMYLTRANSFERASE; LACTATE DEHYDROGENASE;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CURCUMIN; ENZYME INHIBITORS; FEMALE; FREE RADICALS; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; OXIDATION-REDUCTION;

EID: 77954373552     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Gnerlich JL, Deshpande AD, Jeffe DB, Sweet A, White N, Margenthaler JA. Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease. J Am Coll Surg 208:341-347, 2009.
2. Deeb DD, Jiang H, Gao X, Divine G, Dulchavsky SA, Gautam SC. Chemosensitization of hormone-refractory prostate cancer cells by curcumin to TRAIL-induced apoptosis. J Exp Ther Oncol 5:81-91, 2005. (Pubitemid 41739368)
3. Fuchs JR, Pandit B, Bhasin D, Etter JP, Regan N, Abdelhamid D, Li C, Lin J, Li PK. Structure-activity relationship studies of curcumin analogues. Bioorg Med Chem Lett 19:2065-2069, 2009.
4. Bongiovanni GA, Soria EA, Eynard AR. Effects of the plant flavonoids silymarin and quercetin on arsenite-induced oxidative stress in CHO-K1 cells. Food Chem Toxicol 45:971-976, 2007.
5. Soria EA, Goleniowski ME, Cantero JJ, Bongiovanni GA. Antioxidant activity of different extracts of Argentinian medicinal plants against arsenic-induced toxicity in renal cells. Hum Exp Toxicol 27:341-346, 2008.
6. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160:1-40, 2006. (Pubitemid 43227479)
7. Labbozzetta M, Notarbartolo M, Poma P, Maurici A, Inguglia L, Marchetti P, Rizzi M, Baruchello R, Simoni D, D'Alessandro N. Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer. Ann N Y Acad Sci 1155:278-283, 2009.
8. Duvoix A, Blasius R, Delhalle S, Schnekenburger M, Morceau F, Henry E, Dicato M, Diederich M. Chemopreventive and therapeutic effects of curcumin. Cancer Lett 223:181-190, 2005.
9. Chinta SJ, Kumar JM, Zhang H, Forman HJ, Andersen JK. Up-regulation of gamma-glutamyltranspeptidase activity following glutathione depletion has a compensatory rather than an inhibitory effect on mitochondrial complex I activity: implications for Parkinson's disease. Free Rad Biol Med 40:1557-1563, 2006.
10. Soria EA, Eynard AR, Quiroga PL, Bongiovanni GA. Differential effects of quercetin and silymarin on arsenite-induced cytotoxicity in two human breast adenocarcinoma cell lines. Life Sci 81:1397-1402, 2007.
11. Ireson C, Orr S, Jones DJ, Verschoyle R, Lim CK, Luo JL, Howells L, Plummer S, Jukes R, Williams M, Steward WP, Gescher A. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res 61:1058-1064, 2001. (Pubitemid 32174425)
12. Ngoc TM, Hung TM, Thuong PT, Na MK, Kim HJ, Ha DT, Min BS, Minh PTH, Bae KH. Inhibition of human low density lipoprotein and high density lipoprotein oxidation by oligostilbenes from rhubarb. Biol Pharm Bull 31:1809-1812, 2008.
13. Sargent JM. The use of the MTT assay to study drug resistance in fresh tumour samples. Recent Results Cancer Res 161:13-25, 2003.
14. Société Française de Biologie Clinique, Scientific committee. Recommendations for determining the catalytic concentration of lactate dehydrogenase in human serum at 30°C. Ann Biol Clin 40:160-164, 1982.
15. Otton R, Soriano FG, Verlengia R, Curi R. Diabetes induces apoptosis in lymphocytes. J Endocrinol 182:145-156, 2004.
16. Bradford M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72:248-254, 1976.
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275, 1951.
18. Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 269:199-225, 2008.
19. Panchal HD, Vranizan K, Lee CY, Ho J, Ngai J, Timiras PS. Early anti-oxidative and anti-proliferative curcumin effects on neuroglioma cells suggest therapeutic targets. Neurochem Res 33:1701-1710, 2008.
20. Hultberg B, Hultberg M. High glutathione turnover in human cell lines revealed by acivicin inhibition of gammaglutamyltranspeptidase and the effects of thiol-reactive metals during acivicin inhibition. Clin Chim Acta 349:45-52, 2004. (Pubitemid 39311987)
21. Ramachandran C, Rodriguez S, Ramachandran R, Raveendran Nair PK, Fonseca H, Khatib Z, Escalon E, Melnick SJ. Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines. Anticancer Res 25:3293-3302, 2005. (Pubitemid 41105203)
22. Limtrakul P, Chearwae W, Shukla S, Phisalphong C, Ambudkar SV. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin. Mol Cell Biochem 296:85-95, 2007.
23. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB. Curcumin and cancer: an "old-age" disease with an "ageold" solution. Cancer Lett 267:133-164, 2008.
24. Chiu TL, Su CC. Curcumin inhibits proliferation and migration by increasing the Bax to Bcl-2 ratio and decreasing NFkappaBp65 expression in breast cancer MDA-MB-231 cells. Int J Mol Med 23:469-475, 2009.
25. Verma S, Tabb MM, Blumberg B. Activation of the steroid and xenobiotic receptor, SXR, induces apoptosis in breast cancer cells. BMC Cancer 9:3, 2009.
26. Hanigan MH, Frierson Jr. HF, Swanson PE, De Young BR. Altered expression of gamma-glutamyltranspeptidase in human tumors. Hum Pathol 30:300-305, 1999. (Pubitemid 29125150)
27. Reuter S, Schnekenburger M, Cristofanon S, Buck I, Teiten MH, Daubeuf S, Eifes S, Dicato M, Aggarwal BB, Visvikis A, Diederich M. Tumor necrosis factor alpha induces gammaglutamyltransferase expression via nuclear factor-kappaB in cooperation with Sp1. Biochem Pharmacol 77:397-411, 2009.
28. Farombi EO, Abarikwu SO, Adedara IA, Oyeyemi MO. Curcumin and kolaviron ameliorate di-n-butylphthalate-induced testicular damage in rats. Basic Clin Pharmacol Toxicol 100:43-48, 2007.